Scholarlink

Background <p>Cardiovascular disease (CVD) is a major global health challenge. Vascular ageing assessment can identify high-risk individuals for effective prevention, but the knowledge, awareness, perceptions, applications, and limitations of vascular ageing assessment in clinical and research settings are limited. This study assessed these aspects among researchers and clinicians.</p> Methods <p>A pilot-tested questionnaire from our previous study was distributed to clinicians and researchers. Participant’s characteristics and percentages for responses on various aspects of vascular ageing including knowledge, awareness, perceptions, applications, and limitations were reported.</p> Results <p>Two hundred seventy-six people completed the survey (aged 47 ± 15 years, 49.6% male, 67.0% researchers, response rate 75.4%). Findings indicated a consensus on the importance of vascular ageing in a research and clinical context. Approximately 75% acknowledged the association between vascular ageing and overall CVD risk. The group identified as most likely to benefit from vascular ageing assessment were individuals with positive family histories of CVD. There was a consensus on the potential for vascular ageing biomarkers to improve CVD risk evaluation and prevention. Over 90% believe that vascular ageing can be modified. However, less than 10% of clinicians currently measure vascular ageing in clinical settings, citing time constraints, cost and lack of guidelines as main barriers.</p> Conclusions <p>This study highlights the perceived value of vascular ageing measures in both research and clinical settings and identifies the challenges and limitations hindering widespread implementation. Addressing the identified challenges may facilitate the integration of vascular ageing assessments into routine clinical practice, potentially improving CVD risk stratification and patient outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

What do Healthcare Professionals Think About Vascular Ageing and Why it is Not Measured in Clinical Practice? A Study by VascAgeNet

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月1日

查看全文
  • Chloe Park,
  • Andrie G. Panayiotou,
  • Areti Triantafyllou,
  • Enrique Rodilla,
  • Tan V. Bui,
  • Andrea Guala,
  • Christopher C. Mayer,
  • Bernhard Hametner,
  • Ioana Mozos,
  • Thomas Weber,
  • Rachel E. Climie

摘要

Background

Cardiovascular disease (CVD) is a major global health challenge. Vascular ageing assessment can identify high-risk individuals for effective prevention, but the knowledge, awareness, perceptions, applications, and limitations of vascular ageing assessment in clinical and research settings are limited. This study assessed these aspects among researchers and clinicians.

Methods

A pilot-tested questionnaire from our previous study was distributed to clinicians and researchers. Participant’s characteristics and percentages for responses on various aspects of vascular ageing including knowledge, awareness, perceptions, applications, and limitations were reported.

Results

Two hundred seventy-six people completed the survey (aged 47 ± 15 years, 49.6% male, 67.0% researchers, response rate 75.4%). Findings indicated a consensus on the importance of vascular ageing in a research and clinical context. Approximately 75% acknowledged the association between vascular ageing and overall CVD risk. The group identified as most likely to benefit from vascular ageing assessment were individuals with positive family histories of CVD. There was a consensus on the potential for vascular ageing biomarkers to improve CVD risk evaluation and prevention. Over 90% believe that vascular ageing can be modified. However, less than 10% of clinicians currently measure vascular ageing in clinical settings, citing time constraints, cost and lack of guidelines as main barriers.

Conclusions

This study highlights the perceived value of vascular ageing measures in both research and clinical settings and identifies the challenges and limitations hindering widespread implementation. Addressing the identified challenges may facilitate the integration of vascular ageing assessments into routine clinical practice, potentially improving CVD risk stratification and patient outcomes.